Philadelphia Trust Company’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-53,500
Closed -$62K 230
2022
Q2
$62K Hold
53,500
0.01% 213
2022
Q1
$58K Hold
53,500
﹤0.01% 238
2021
Q4
$39K Buy
+53,500
New +$43.3K ﹤0.01% 225

Philadelphia Trust Company's MBII Position: Q3 2022 in Review

Philadelphia Trust Company sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 53,500 shares — an estimated $62K sold.

Philadelphia Trust Company first reported a position in MBII in Q4 2021 and held it in 3 quarters. The position peaked at $62K in Q2 2022. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

  • Philadelphia Trust Company reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
  • Philadelphia Trust Company sold 53,500 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $62K.
  • Philadelphia Trust Company first reported a position in Marrone Bio Innovations, Inc. in Q4 2021 and held it in 3 quarters.
  • Philadelphia Trust Company's Marrone Bio Innovations, Inc. position peaked at $62K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Philadelphia Trust Company's 13F filing for Q3 2022, filed 10 Nov 2022.